Emili 1983.

Methods	Single‐site study Randomization: noted, but method not stated Blinding: participants, providers
Participants	Geographic region: Italy Study setting: community N = 30 Baseline symptom score: NR Baseline prostate volume: NR Mean age (range): NR (44 to 78) years Race: white Diagnostic criteria: men with manageable BPH
Interventions	Control: matching placebo Treatment: Permixon 160 mg twice daily Study duration: 4 weeks Lost to follow‐up: n = 0
Outcomes	Peak urine flow Mean urine flow Bladder residual volume Prostate size (qualitative scale used) Nocturia Dropouts due to side effects: none
Notes	Exclusions: prior treatment for BPH Full text not available for this update.